Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post Market Surveillance Study of the Performance and Safety of UT 380® Contraceptive Intra Uterine Device in Nulliparous, Uniparous and Multiparous Women

NCT03642171 is registered in ClinicalTrials.gov with Quanta Medical as lead sponsor.

NCT NCT03642171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03642171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post Market Surveillance Study of the Performance and Safety of UT 380® Contraceptive Intra Uterine Device in Nulliparous, Uniparous and Multiparous Women
Lead sponsor
Quanta Medical
Phase
Observational
Overall status
Completed
Start date
July 26, 2018
Completion date
September 23, 2024
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contraceptive; complications, intrauterine